Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges.
Saved in:
| Title: | Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges. |
|---|---|
| Authors: | Choucair K; Department of Oncology, Wayne State University School of Medicine, Detroit, MI, USA., Imtiaz H; Department of Oncology, Wayne State University School of Medicine, Detroit, MI, USA., Uddin MH; Department of Oncology, Wayne State University School of Medicine, Detroit, MI, USA., Nagasaka M; Department of Division of Hematology/Oncology and Medicine, School of Medicine University of California Irvine, Irvine, CA, USA., Al-Hallak MN; Department of Oncology, Wayne State University School of Medicine, Detroit, MI, USA., Philip PA; Henry Ford Health Systems, Detroit, MI, USA., El-Rayes B; Department of Internal Medicine, Department of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Pasche BC; Department of Oncology, Wayne State University School of Medicine, Detroit, MI, USA., Azmi AS; Department of Oncology, Wayne State University School of Medicine, Detroit, MI, USA. azmia@karmanos.org. |
| Source: | Signal transduction and targeted therapy [Signal Transduct Target Ther] 2025 Nov 28; Vol. 10 (1), pp. 385. Date of Electronic Publication: 2025 Nov 28. |
| Publication Type: | Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
